NCT06325189

Effects of Aerobic Interval Training on Fatigue Level and Functional Performance in Post Angioplasty Patients

Riphah International University·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov
Study focus
Disease/Condition
Coronary Artery Disease
Drug/Device/Intervention
Aerobic Interval Training
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Riphah International University
Location
Lahore, Pakistan
Timeline & enrollment
Phase
N/A
Start date
Jul 20, 2023
End date
Dec 10, 2023
Enrollment
47 participants
Primary outcome

Fatigue Severity Scale,Six Minute Walk Test,1 minute sit to stand:

Summary

The goal of this randomized controlled trial is to determine the effects of aerobic interval
 training on levels of tiredness and functional performance in post-angioplasty patients. The
 main question it aims to answer is:
 
 Does aerobic interval training reduce fatigue and improve functional performance compared to
 medication alone in post-angioplasty patients?
 
 Participants will:
 
 Be randomly assigned to either the control group (medication) or the experimental group
 (medication + aerobic interval training) Perform aerobic interval training for 30 minutes,
 three times a week, for six weeks (experimental group only) Complete pre and
 post-intervention assessments using the fatigue severity scale, the 6-minute walk test, and
 the one minute sit to stand test Researchers will compare the two groups to see if aerobic
 interval training leads to significant improvements in fatigue levels and functional
 performance.

ICD-10 classifications
Cardiovascular disease, unspecifiedAtherosclerotic cardiovascular disease, so describedAtherosclerotic heart diseaseAbnormal findings on diagnostic imaging of heart and coronary circulationCoronary vasodilators, not elsewhere classified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06325189
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06325189 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Completed. The study focuses on Coronary Artery Disease. Target enrollment is 47 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.